Press Releases: Page 5
Post a press release | Manage press releases
-
ROIS CDMO Acquires Pheonix Site
Press release from ROIS CDMO • Oct. 7, 2025 -
Boyd Biomedical Releases Study on Patient-Centric Medical Device Commercialization
Press release from Boyd Biomedical • Oct. 7, 2025 -
BrYet US, Inc. Receives Approval to Initiate in Australia a First-in-Human Phase 1/2 Trial of ML-016 in Advanced Cancers with Lung and/or Liver Involvement
Press release from BrYet US Inc • Oct. 6, 2025 -
MMS Announces Its Role in Supporting Gates Ventures and the GNPC to Deliver One of the World's Largest Proteomic Datasets for Neurodegenerative Diseases
Press release from MMS • Oct. 2, 2025 -
Mercury Bio Reports Positive Results from Preclinical Study Evaluating Novel Drug Delivery Technology Transporting Protein Cargo to the Brain
Press release from Mercury Bio • Oct. 1, 2025 -
MMS Named Finalist in Citeline’s 2025 Scrip Awards for Best Contract Research Organization (CRO) – Specialist Providers
Press release from MMS • Sept. 25, 2025 -
Where Innovation and Vision Drive Progress - ACI's Inaugural West Coast WILS Summit
Press release from American Conference Institute • Sept. 24, 2025 -
Renowned Oncologist and Hematologist Serves on the Editorial Board of MerckManuals.com
Press release from MerckManuals.com • Sept. 24, 2025 -
Samsung Biologics' Majority Union Files Formal Complaints on ESG, Labor Failures
Press release from Samsung Biologics Labor Union • Sept. 23, 2025 -
N4 Pharma collaboration with SRI International demonstrates Nuvec® nanoparticle successfully targets lung cancer cells
Press release from N4 Pharma • Sept. 22, 2025 -
Frame Bio Licenses Novel Drug Delivery Technology from Mercury Bio to Develop Regenerative Therapies for Bone and Collagen Diseases and Disorders
Press release from Frame Bio LLC • Sept. 17, 2025 -
TransCelerate and Tufts CSDD Uncover Opportunities to Rethink Data Collection and Optimize Protocol Design
Press release from TransCelerate BioPharma • Sept. 17, 2025 -
Sapio Sciences Introduces World’s First 3rd-Generation ELN
Press release from Sapio Sciences • Sept. 16, 2025 -
Zymewire Releases Midyear 2025 Biopharma Report, Enriched with Executive Commentary from Q2 Earnings Calls
Press release from Zymewire • Sept. 16, 2025 -
CurQD® Marks Milestone with First Real-World Crohn’s Disease Study
Press release from SF Tribune • Sept. 14, 2025 -
Infectious Diseases Expert Joins the Editorial Board of MerckManuals.com
Press release from MerckManuals.com • Sept. 10, 2025 -
Cliniphai and Gibson Research Consultancy Partner to Streamline Global COA and eCOA Translation Workflows
Press release from Cliniphai • Sept. 9, 2025 -
Sapio Sciences and Ultima Genomics Partner to Advance Multi-Omics Research
Press release from Sapio Sciences • Sept. 9, 2025 -
Proscia Unveils Aperture, Making the Moment of Diagnosis the Gateway to Life-Saving Treatments for More Patients
Press release from Proscia.com • Sept. 8, 2025 -
Rapafusyn Pharmaceuticals Closes Over-Subscribed $44 Million Series A Financing to Advance Its Non-Degrading Molecular Glue Drug Discovery Platform
Press release from Rapafusyn Research and Development • Sept. 4, 2025
Previous
